7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Janda K et al. | Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. | 2013 | Pol. Arch. Med. Wewn. | pmid:23535831 |
Tripuwabhrut P et al. | Effect of compressive force on human osteoblast-like cells and bone remodelling: an in vitro study. | 2013 | Arch. Oral Biol. | pmid:23583016 |
Recht M et al. | The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption. | 2013 | Haemophilia | pmid:23731369 |
Wu X et al. | Screening of osteoprotegerin-related feature genes in osteoporosis and functional analysis with DNA microarray. | 2013 | Eur. J. Med. Res. | pmid:23731710 |
Araújo AA et al. | Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis. | 2013 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:23775504 |
Rozas Moreno P et al. | Serum osteoprotegerin: bone or cardiovascular marker in Type 2 diabetes males? | 2013 | J. Endocrinol. Invest. | pmid:22391059 |
Crosley LK et al. | The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. | 2013 | Mol Nutr Food Res | pmid:23934705 |
Zhang J et al. | Feeding blueberry diets to young rats dose-dependently inhibits bone resorption through suppression of RANKL in stromal cells. | 2013 | PLoS ONE | pmid:23936431 |
Bezerra JP et al. | Effects of estrogen deficiency and/or caffeine intake on alveolar bone loss, density, and healing: a study in rats. | 2013 | J. Periodontol. | pmid:22873654 |
Yabumoto T et al. | Stabilization of tooth movement by administration of reveromycin A to osteoprotegerin-deficient knockout mice. | 2013 | Am J Orthod Dentofacial Orthop | pmid:23992809 |
Steagall WK et al. | Osteoprotegerin contributes to the metastatic potential of cells with a dysfunctional TSC2 tumor-suppressor gene. | 2013 | Am. J. Pathol. | pmid:23867796 |
Anastasilakis AD et al. | Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial. | 2013 | J. Clin. Endocrinol. Metab. | pmid:23788684 |
Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
Kato R et al. | Gap-junction-mediated communication in human periodontal ligament cells. | 2013 | J. Dent. Res. | pmid:23677649 |
Weng CH et al. | [Effects of shangke jiegu tablet on the gene expressions of osteoprotegerin and osteoprotegerin ligand in the repairing process of mandibular defect rabbits]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:23596799 |
Palumbo S and Li WJ | Osteoprotegerin enhances osteogenesis of human mesenchymal stem cells. | 2013 | Tissue Eng Part A | pmid:23597005 |
Liu CG et al. | [Effect of Erigeron Breviscapus on the expression of OPG/RANKL/RANK in osteoblasts and pre-osteoclasts in vitro]. | 2013 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:24517065 |
Owen S et al. | Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer. | 2013 | Anticancer Res. | pmid:23267146 |
Lazzerini PE et al. | Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. | 2013 | Joint Bone Spine | pmid:22999910 |
Feng ZY et al. | Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. | 2013 | Mol Med Rep | pmid:24126801 |
Wang X et al. | Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation. | 2013 | Chin. J. Traumatol. | pmid:24103822 |
Lotinun S et al. | Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. | 2013 | J. Clin. Invest. | pmid:23321671 |
Saki F et al. | Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation. | 2013 | J. Bone Miner. Res. | pmid:23322328 |
Srivastava S et al. | Role of vanadium (V) in the differentiation of C3H10t1/2 cells towards osteoblast lineage: a comparative analysis with other trace elements. | 2013 | Biol Trace Elem Res | pmid:23325289 |
Mogelvang R et al. | Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. | 2013 | Heart | pmid:23135978 |
Wolf M et al. | Potential role of high mobility group box protein 1 and intermittent PTH (1-34) in periodontal tissue repair following orthodontic tooth movement in rats. | 2013 | Clin Oral Investig | pmid:22777389 |
Deng YH et al. | The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. | 2013 | Endocrine | pmid:22798246 |
Giganti MG et al. | Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. | 2012 Oct-Dec | J. Biol. Regul. Homeost. Agents | pmid:23241117 |
Heitzer E et al. | IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. | 2012 Nov-Dec | Pain Physician | pmid:23159968 |
Nuño-Arana I et al. | Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. | 2012 Jul-Aug | Am. J. Hum. Biol. | pmid:22434650 |
Varsavsky M et al. | Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. | 2012 Jul-Aug | J. Androl. | pmid:21903971 |
Dalezis P et al. | Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. | 2012 Jan-Feb | In Vivo | pmid:22210719 |
Ambroszkiewicz J et al. | [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. | 2012 Apr-Jun | Med Wieku Rozwoj | pmid:22971655 |
Wang N et al. | Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. | 2012 | Mol. Endocrinol. | pmid:22108801 |
Boumans MJ et al. | Rituximab abrogates joint destruction in rheumatoid arthritis by inhibiting osteoclastogenesis. | 2012 | Ann. Rheum. Dis. | pmid:22072013 |
Chen X et al. | Cadmium stimulates the osteoclastic differentiation of RAW264.7 cells in presence of osteoblasts. | 2012 | Biol Trace Elem Res | pmid:22076734 |
Bilgir O et al. | Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. | 2012 | Transfus. Apher. Sci. | pmid:22079264 |
Robinson DE et al. | Glycosaminoglycan (GAG) binding surfaces for characterizing GAG-protein interactions. | 2012 | Biomaterials | pmid:22079008 |
Rojano-MejÃa D et al. | TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. | 2012 | Maturitas | pmid:22079369 |
Aliprantis AO et al. | Transient muscle paralysis degrades bone via rapid osteoclastogenesis. | 2012 | FASEB J. | pmid:22125315 |
Ueland T et al. | TNF revisited: osteoprotegerin and TNF-related molecules in heart failure. | 2012 | Curr Heart Fail Rep | pmid:22453763 |
Bogliolo L et al. | Biomarkers and prognostic stratification in psoriatic arthritis. | 2012 | Reumatismo | pmid:22690385 |
Olesen M et al. | No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. | 2012 | Mol. Cell. Endocrinol. | pmid:22698523 |
Cvija H et al. | Chemotactic and immunoregulatory properties of bone cells are modulated by endotoxin-stimulated lymphocytes. | 2012 | Inflammation | pmid:22699680 |
Kim H et al. | Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. | 2012 | Arch. Gynecol. Obstet. | pmid:22392486 |
Liu S et al. | Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. | 2012 | Hum. Cell | pmid:22399266 |
Zhao NN et al. | [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. | 2012 | Beijing Da Xue Xue Bao | pmid:22353912 |
Zupan J et al. | The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. | 2012 | J. Biomed. Sci. | pmid:22380539 |
Chai YC et al. | Ectopic bone formation by 3D porous calcium phosphate-Ti6Al4V hybrids produced by perfusion electrodeposition. | 2012 | Biomaterials | pmid:22381474 |
Hudson JB et al. | Local delivery of recombinant osteoprotegerin enhances postorthodontic tooth stability. | 2012 | Calcif. Tissue Int. | pmid:22382900 |
Singh DK et al. | Prevalence and progression of peripheral vascular calcification in type 2 diabetes subjects with preserved kidney function. | 2012 | Diabetes Res. Clin. Pract. | pmid:22386825 |
Jia P et al. | The effect of alendronate on the expression of osteopontin and osteoprotegerin in calcified aortic tissue of the rat. | 2012 | Eur. J. Pharmacol. | pmid:22387856 |
Zhang L et al. | Effect of heat stress on the expression levels of receptor activator of NF-κB ligand and osteoprotegerin in human periodontal ligament cells. | 2012 | Int Endod J | pmid:21899569 |
Hosbond SE et al. | Osteoprotegerin as a marker of atherosclerosis: a systematic update. | 2012 | Scand. Cardiovasc. J. | pmid:22506827 |
Fossmark R et al. | Decreased bone mineral density and reduced bone quality in H(+) /K(+) ATPase beta-subunit deficient mice. | 2012 | J. Cell. Biochem. | pmid:21882222 |
Oka H et al. | Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. | 2012 | J. Periodontol. | pmid:21910594 |
Wang JQ et al. | [Effects of static magnetic field at different times on the proliferation and differentiation of osteoblasts in vitro]. | 2012 | Zhongguo Gu Shang | pmid:23427595 |
Altan BA et al. | Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement. | 2012 | Lasers Med Sci | pmid:21038101 |
Chen WH et al. | Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. | 2012 | Chin J Integr Med | pmid:22549392 |
Zheng D et al. | The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. | 2012 | Bone | pmid:22551876 |
Lee JW et al. | Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. | 2012 | J Nat Med | pmid:21656335 |
Wang YD et al. | Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. | 2012 | Horm. Metab. Res. | pmid:22556124 |
Larussa T et al. | No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. | 2012 | World J. Gastroenterol. | pmid:22529691 |
Niu YB et al. | The beneficial effect of Radix Dipsaci total saponins on bone metabolism in vitro and in vivo and the possible mechanisms of action. | 2012 | Osteoporos Int | pmid:22535190 |
Hou JM et al. | Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22902986 |
Ma B et al. | Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. | 2012 | Acta Pharmacol. Sin. | pmid:22426695 |
GarcÃa-MartÃn A et al. | [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. | 2012 | Med Clin (Barc) | pmid:22024564 |
Zijlstra WP et al. | Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. | 2012 | J. Orthop. Res. | pmid:22025323 |
Zhao N et al. | Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. | 2012 | Orthod Craniofac Res | pmid:22264323 |
Erkol A et al. | Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. | 2012 | Atherosclerosis | pmid:22265272 |
Martin CK et al. | Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. | 2012 | Oral Oncol. | pmid:22265717 |
Reginster JY et al. | Strontium ranelate treatment increases osteoprotegerin serum levels in postmenopausal osteoporotic women. | 2012 | Bone | pmid:22270053 |
Dong W et al. | [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. | 2012 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:23268391 |
Feng Y et al. | AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. | 2012 | Chin. Med. J. | pmid:22964327 |
Pedersen S et al. | Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. | 2012 | Cardiology | pmid:22964478 |
Bargman R et al. | High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. | 2012 | Pediatr. Res. | pmid:22926546 |
Cauley JA | Commentary: A single biomarker in a complex metabolic pathway. | 2012 | Int J Epidemiol | pmid:22933649 |
Deuell KA et al. | RANKL enhances macrophage paracrine pro-calcific activity in high phosphate-treated smooth muscle cells: dependence on IL-6 and TNF-α. | 2012 | J. Vasc. Res. | pmid:22948607 |
Li F et al. | Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. | 2012 | Fitoterapia | pmid:22951288 |
Guo D et al. | Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. | 2012 | Mol. Cell. Biochem. | pmid:22167620 |
Svensson M et al. | Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. | 2012 | Nephrol. Dial. Transplant. | pmid:22172725 |
Kraus D et al. | Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. | 2012 | Clin Oral Investig | pmid:22186940 |
Zhao N et al. | Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. | 2012 | Am J Orthod Dentofacial Orthop | pmid:22196183 |
Chen J et al. | OPG inhibits gene expression of RANK and CAII in mouse osteoclast-like cell. | 2012 | Rheumatol. Int. | pmid:22210270 |
Giannopoulou C et al. | Immunohistochemical expression of RANKL, RANK and OPG in gingival tissue of patients with periodontitis. | 2012 | Acta Odontol. Scand. | pmid:22214279 |
Bloch SL and Sørensen MS | Otosclerosis: a perilabyrinthine threshold phenomenon. | 2012 | Acta Otolaryngol. | pmid:22217131 |
Li YL and Wang H | [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. | 2012 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:22989431 |
Kim IS et al. | Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. | 2012 | J. Dent. Res. | pmid:23086742 |
Xu Y et al. | [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803436 |
Zhu XF et al. | [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. | 2012 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22803437 |
Nyrnes A et al. | Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study. | 2012 | Gend Med | pmid:23046763 |
Davenport C et al. | The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. | 2012 | Eur. J. Clin. Invest. | pmid:22803952 |
Brandenburg V et al. | Calcification inhibitors in vascular calciphylaxis associated with normal renal function. | 2012 | Thromb. Haemost. | pmid:23092963 |
Histing T et al. | Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling. | 2012 | J. Surg. Res. | pmid:20888595 |
Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
Ryser MD et al. | Osteoprotegerin in bone metastases: mathematical solution to the puzzle. | 2012 | PLoS Comput. Biol. | pmid:23093918 |
Kleyer A et al. | Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss. | 2012 | J. Bone Miner. Res. | pmid:22806960 |
Wang C et al. | Susceptibility genes for osteoporotic fracture in postmenopausal Chinese women. | 2012 | J. Bone Miner. Res. | pmid:22807154 |
Poerschke RL et al. | Major differences among chemopreventive organoselenocompounds in the sustained elevation of cytoprotective genes. | 2012 | J. Biochem. Mol. Toxicol. | pmid:22807314 |
Tenta R et al. | Association between circulating levels of adiponectin and indices of bone mass and bone metabolism in middle-aged post-menopausal women. | 2012 | J. Endocrinol. Invest. | pmid:21606670 |